3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase NA
6
Phase 3
2
Phase EARLY_PHASE1
1
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Breast
1
Conditions
Breast Neoplasms
277
Pain, Postoperative
14
Neoplasm Metastasis
12
Neoplasms
9
Prostatic Neoplasms
8
Ovarian Neoplasms
7
Triple Negative Breast Neoplasms
6
Pain
6
Osteoporosis
6
Seroma
5
Colorectal Neoplasms
5
Cardiotoxicity
5
Breast Diseases
4
Breast Cancer Female
4
Neutropenia
3
Melanoma
3
Mastodynia
3
Lymphedema
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Brain Neoplasms
3
Bone Diseases, Metabolic
3
Vomiting
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sleep Initiation and Maintenance Disorders
2
Skin Diseases
2
Obesity
2
Neurotoxicity Syndromes
2
Multiple Myeloma
2
Interventions
Zoledronic Acid
1
Standard of Care
1
Diphosphonates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplastic Cells, Circulating
×
Breast
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts